This Drug Plus Diet And Exercise Can Help Obese Adolescents

Bauer, Jeff
August 2005
RN;Aug2005, Vol. 68 Issue 8, p77
Academic Journal
Focuses on a study which showed that orlistat (Xenical) combined with a low-calorie diet and exercise, can help overweight and obese adolescents lose weight and keep it off. Subjects of the study; Procedures; Side effects of orlistat.


Related Articles

  • Orlistat and Low-Cal Diet Whips LDL and Weight Into Shape.  // Diabetes Health;Feb/Mar2007, Vol. 16 Issue 1, p30 

    The article presents the result of a study which examined the efficacy of orlistat (Xenical) and a low-calorie diet in reducing body weight. The study found that 60 milligrams of orlistat, combined with a low-calorie diet, reduced the low density lipoprotein cholesterol and weight of study...

  • In Search of the Magic Pill. Bernet, Dorothy; Whittle, Stacey // Equities;Apr2007, Vol. 55 Issue 2, p95 

    The article looks at several weight loss medications available in the U.S. It mentions that the lipase inhibitor Xenical from Roche Laboratories Inc. has shown to be moderately effective in assisting obese people to lose weight. Also highlighted in the article are various natural ways of weight...

  • Short-term Administration of Orlistat Reduced Daytime Triglyceridemia in Obese Women With the Metabolic Syndrome. Tzotzas, Themistoklis; Samara, Martha; Constantinidis, Theodoros; Tziomalos, Konstantinos; Krassas, Gerasimos // Angiology;Feb/Mar2007, Vol. 58 Issue 1, p26 

    The objective of this prospective, controlled, randomized study was to evaluate the effect of orlistat administration for 10 days on daytime capillary triglyceridemia in obese women with metabolic syndrome (MetSyn). Thirty-two obese, nondiabetic women with MetSyn were evaluated. The presence of...

  • Orlistat: A Viewpoint by F. Xavier Pi-Sunyer. Pi-Sunyer, F.X. // Drugs;Aug1998, Vol. 56 Issue 2, p250 

    Offers views on the anti-obesity drug orlistat. Mechanism of actio; Toxicity; Effectiveness.

  • Orlistat. McNeely, W.; Benfield, P. // Drugs;Aug1998, Vol. 56 Issue 2, p241 

    â–´ Orlistat (tetrahydrolipstatin) is an inhibitor of pancreatic and other lipases. As a pancreatic lipase inhibitor, it acts in the gastrointestinal lumen and is indicated for use in obesity. â–´ Serum total cholesterol and low density lipoprotein-cholesterol levels were reduced in...

  • Orlistat: A Viewpoint by Madeleine L. Drent. Drent, M.L. // Drugs;Aug1998, Vol. 56 Issue 2, p250 

    Offers views on the anti-obesity drug orlistat. Physiological effects of orlistat; Effectiveness; Adverse effects.

  • Orlistat.  // Reactions Weekly;9/17/2011, Issue 1369, p30 

    The article describes the case of a woman who developed a lichenoid drug eruption (LDE) following treatment with orlistat for obesity.

  • The Management of Hypertension in the Overweight and Obese Patient: Is Weight Reduction Sufficient? Douketis, James D.; Sharma, Arya M. // Drugs;2004, Vol. 64 Issue 8, p795 

    The management of hypertension in the overweight and obese patient is a frequently encountered but under investigated clinical problem. The conventional management of such patients involves weight reduction with dietary therapy or a combined approach with dietary and anti-obesity drug therapy....

  • Orlistat, sibutramine, and rimonabant reduce weight in overweight and obese persons. Kanaya, Alka M. // ACP Journal Club;Mar/Apr2008, Vol. 148 Issue 2, p24 

    The article focuses on 30 randomized controlled trials (RCTs) investigating the long-term efficacy of antiobesity drugs (AODs) for reducing weight and improving health status in overweight or obese persons. Trials found out that orlistat, sibutramine and rimonabant reduces weight and improve...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics